title: Prevalence of carnitine depletion in critically ill patients with undernutrition.
abstract: The aim of this study was to evaluate to what extent secondary carnitine deficiency may exist based on the prevalence of subnormal carnitine status in patients with critical illness and abnormal nutritional state. Healthy control patients (n = 12) were investigated and compared with patients with possible secondary carnitine deficiency, ie, patients with overt severe protein-energy malnutrition (PEM, n = 28), postoperative long-term (greater than 14 days) parenteral glucose feeding (250 g glucose/d, n = 7), severe liver disease (n = 10), renal insufficiency (n = 7), and sustained septicemia with increased metabolic rate (n = 8). Nutritional status, energy expenditure, creatinine excretion, and blood biochemical tests were measured in relationship to free and total carnitine concentrations in plasma and skeletal muscle tissue, as well as urinary excretion of free and total carnitine. The overall mortality rate was 48% within 30 days of the investigation in study patients with the highest mortality in liver disease (90%). The hospitalization range was 14 to 129 days in study patients. Most study patients had lost weight (4% to 19%) and had abnormal body composition. Patients with liver disease, septicemia, renal insufficiency, and those on long-term glucose feeding had significantly higher than predicted metabolic rate (+25% +/- 3%), while patients with severe malnutrition had decreased metabolic rate compared with controls. Patients with liver disease had increased plasma concentrations of free (96 +/- 16 mumol/L) and total (144 +/- 27 mumol/L) carnitine compared with controls (45 +/- 3, 58 +/- 7 mumol/L, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Surgery and Anaesthesiology, Sahlgrenska Hospital, University of Göteborg, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Wennberg
authors.forename: A
authors.initials: A
authors.lastname: Hyltander
authors.forename: A
authors.initials: A
authors.lastname: Sjöberg
authors.forename: B
authors.initials: B
authors.lastname: Arfvidsson
authors.forename: R
authors.initials: R
authors.lastname: Sandström
authors.forename: I
authors.initials: I
authors.lastname: Wickström
authors.forename: K
authors.initials: K
authors.lastname: Lundholm
mesh_terms: D000368:Aged; D002331:Carnitine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D016638:Critical Illness; D005260:Female; D006440:Hemofiltration; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism* / Q000628:therapy; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D009748:Nutrition Disorders / Q000378:metabolism*; D010288:Parenteral Nutrition; D011182:Postoperative Care; D011502:Protein-Energy Malnutrition / Q000378:metabolism*; D018805:Sepsis / Q000378:metabolism*
chemical_list: D002331:Carnitine